Financial advisory appointment to support planned acquisitions of profitable, revenue-generating businesses during 2027 DUBLIN, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ: DAVI) (“Davion” or the “Company”), a developer of non-invasive health monitoring technologies, announces
First in a planned programme of acquisitions to expand Davion’s revenues, earnings and healthcare operations DUBLIN, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (NASDAQ: DAVI) (“Davion” or the “Group”), a developer of non-invasive health monitoring technologies, announces that it has
Acquisition adds battery-free smart wound dressing and two-minute multi-marker screening test to Davion’s growing healthcare portfolio DUBLIN, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Davion Healthcare Plc (Nasdaq: DAVI) ("Davion" or the "Company"), a next-generation digital healthcare company developing
Ordinary shares expected to commence trading on Nasdaq Global Market on Thursday 22 October 2026 under ticker "DAVI" Glenn Williams appointed Chief Executive Officer and Jeremy North Chief Operating Officer, effective on commencement of trading New Operational Directorate established to lead
